drugset / Trial / NCT03920579

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

NCT03920579

Phase 1 Unknown 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

a study to investigate the pharmacokinetic characteristics and safety/tolerability according to formulations of CKD-386 in healthy male volunteers

Timeline

Start
2019-04-01
Primary completion
2019-05
Completion
2019-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-386 Unknown Oral
Subject D013 Unknown Oral
Subject D326 Unknown Oral
Subject D337 Unknown Oral